Silexion Therapeutics Corp. (SLXN)
NASDAQ · Healthcare
Silexion Therapeutics Corp. Total Liabilities 2023–2025
Silexion Therapeutics Corp. annual total liabilities history from 2023 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Silexion Therapeutics Corp. total liabilities as of December 31, 2025: 4.6M, a 32.69% decrease year-over-year.
- Silexion Therapeutics Corp. total liabilities for 2025 were 4.6M, a 32.69% decrease from 2024.
- Silexion Therapeutics Corp. total liabilities for 2024 were 6.9M, a 203.86% increase from 2023.
- Silexion Therapeutics Corp. total liabilities for 2023 were 2.3M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Silexion Therapeutics Corp. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $5 |
| 2024 | $7 |
| 2023 | $2 |
Silexion Therapeutics Corp. Total Liabilities — FAQ
Silexion Therapeutics Corp. (SLXN) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SLXN's total liabilities history?
The chart and table above show Silexion Therapeutics Corp.'s total liabilities by year and by quarter, including the growth rate.